Adc Therapeutics SA
ADCT
Get informed when a big investor buys or sells
+ FollowMarket Cap$183.84M
Close$
$-1.86
229.1% downside
Current Fair Value
229.1% downsideOvervalued by 229.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $183.84 Million |
|---|---|
| Enterprise Value | $381.84 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.12 |
| Beta | 1.86 |
| Outstanding Shares | 155,016,023 |
Return
| Return on Equity | 42.47% |
|---|---|
| Return on Assets | -34.69% |
| Return on Invested Capital | -57.34% |
Valuation & Multiples
| P/E Ratio | -2.17 |
|---|---|
| PEG | 3.07 |
| Price to Sales | - |
| Price to Book Ratio | -0.72 |
| Enterprise Value to Revenue | 4.8 |
| Enterprise Value to EBIT | -3.45 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 1.09 |
| Debt to Equity | -1.83 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$18.89 M
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$18.69 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 176,400▼ 8.27% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 52.24%▼ 1.94% |
|---|---|
| Total Invested | $86.98M▼ 72.20% |
| Investors Holding | 118▼ 4.00% |
ESG Score
No data